Zobrazeno 1 - 3
of 3
pro vyhledávání: '"John P, Bullivant"'
Autor:
Jorge A. Cardenas, John P. Bullivant, Igor V. Kolesnichenko, Devin J. Roach, Michael A. Gallegos, Eric N. Coker, Timothy N. Lambert, Eric Allcorn, A. Alec Talin, Adam W. Cook, Katharine L. Harrison
Publikováno v:
ACS Applied Materials & Interfaces. 14:45342-45351
Autor:
Jon Dobson, Christopher D. Batich, John P. Bullivant, Shan Zhao, Brad J. Willenberg, Bettina Kozissnik
Publikováno v:
International Journal of Molecular Sciences, Vol 14, Iss 9, Pp 17501-17510 (2013)
Feraheme, is a recently FDA-cleared superparamagnetic iron oxide nanoparticle (SPION)-based MRI contrast agent that is also employed in the treatment of iron deficiency anemia. Feraheme nanoparticles have a hydrodynamic diameter of 30 nm and consist
Externí odkaz:
https://doaj.org/article/18dd78fa06b24c91af4d2e7315c148f2
Autor:
Bettina Kozissnik, Jon Dobson, Brad J Willenberg, Shan Zhao, John P Bullivant, Christopher D. Batich
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 14; Issue 9; Pages: 17501-17510
International Journal of Molecular Sciences, Vol 14, Iss 9, Pp 17501-17510 (2013)
International Journal of Molecular Sciences; Volume 14; Issue 9; Pages: 17501-17510
International Journal of Molecular Sciences, Vol 14, Iss 9, Pp 17501-17510 (2013)
Feraheme, is a recently FDA-cleared superparamagnetic iron oxide nanoparticle (SPION)-based MRI contrast agent that is also employed in the treatment of iron deficiency anemia. Feraheme nanoparticles have a hydrodynamic diameter of 30 nm and consist